Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone TAPB vs PCIA for postoperative analgesia after abdominal surgery
ChiCTR2600117788Phase 4Not yet recruiting
- Sponsor
- Yibin Second People's Hospital
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hydromorphone in postoperative pain (2 arms), sponsored by Yibin Second People's Hospital. Primary endpoints: NRS score, Number of rescue analgesia administrations within 48 hours post-surgery and 2 more. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600117788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117788.